Share
USER HOTLINE: call us at +49 30 65499 145 | Not all products are available in the USA.
News & Media

Events

  • Paris, France
    23 June 2025 - 24 June 2025
    ECOS-TCS 2025
  • Vicenza, Italy
    1:00 pm - 1:45 pm
    24 June 2025
    Symposium: Update on hemoadsorption in critical care patients
  • Online
    3:00 pm - 4:00 pm
    25 June 2025
    Der Grundsatz der evidenzbasierten Medizin
  • Birmingham, UK
    30 June 2025 - 3 July 2025
    SOA 2025
  • Copenhagen, Denmark
    8 October 2025 - 11 October 2025
    EACTS Annual Meeting 2025
  • Munich, Germany
    25 October 2025 - 29 October 2025
    ESICM Lives 2025
CytoSorbents

Voices around the world

world map
Critical Care Liver
Dr. Pavlo Prylutzki
Minsk, Belarus

In these patients, it could give us one or two days to win time and to give the liver some time to start working.

Critical Care
Dr. Voyka Gorjup
Ljubljana, Slovenia

The most prominent clinical effect is the lowering of vasopressors, hemodynamic stability, lowering of interleukins and in those patients who are on vvECMO…

Kidney
Dr. Filipo Aucella
San Giovanni, Italy

When we started to use CytoSorb®, we were very impressed by the rapid decrease of myoglobin concentrations, and the renal damage also improved very rapidly.